Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Ascending-Dose and Multiple-Ascending-Dose Study of BIIB059 in Healthy Volunteers and Subjects With Systemic Lupus Erythematosus

NCT02106897 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT02106897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02106897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Ascending-Dose and Multiple-Ascending-Dose Study of BIIB059 in Healthy Volunteers and Subjects With Systemic Lupus Erythematosus
Lead sponsor
Biogen
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2014
Completion date
May 24, 2016
Enrollment
109 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers, systemic lupus erythematosus